表紙
市場調查報告書

全球神經調節市場:成長,趨勢,預測

Neuromodulation Market - Growth, Trends, and Forecast (2019 - 2024)

出版商 Mordor Intelligence LLP 商品編碼 661184
出版日期 內容資訊 英文 118 Pages
商品交期: 2-3個工作天內
價格
全球神經調節市場:成長,趨勢,預測 Neuromodulation Market - Growth, Trends, and Forecast (2019 - 2024)
出版日期: 2019年12月01日內容資訊: 英文 118 Pages
簡介

本報告提供全球神經調節市場相關調查,彙整市場趨勢與各市場區隔趨勢,各地區預測,加入此市場的主要企業的簡介等相關資訊。

第1章 簡介

第2章 調查方法

第3章 摘要整理

第4章 市場趨勢

  • 市場概要
  • 推動市場的要素
  • 阻礙市場的要素
  • 波特的五力分析

第5章 市場區隔

  • 各技術
    • 體內神經調節
    • 體外神經調節(非侵入性)
  • 各用途
    • 帕金森氏症
    • 憂鬱症
    • 慢性疼痛
    • 脊椎手術後疼痛症候群
    • 缺血疾病
    • 尿失禁
    • 大便失禁
    • 癲癇
    • 胃輕癱
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東·非洲
    • 南美

第6章 競爭環境

  • 企業簡介
    • Medtronic PLC
    • Boston Scientific Corporation
    • St. Jude Medical Inc.
    • Synapse Biomedical Inc.
    • Nevro Corporation
    • Neurosigma Inc.
    • Neuropace Inc.
    • Neuronetics Inc.
    • Cyberonics Inc.
    • BioControl Medical

第7章 市場機會與未來趨勢

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 60473

Market Overview

Neurological diseases are frequent in older adults, affecting around 55% of people age 55 and older. They are associated with a high risk for adverse health outcomes, including mortality, disability, institutionalization, and hospitalization. Degenerative diseases, like dementia and Parkinson's disease, as well as strokes and headaches, are frequently encountered neurological diseases in elderly patients. Neuromodulation is an intracranial, electrical neuromodulation therapy that has FDA approval for the treatment for most of the neurological diseases such as bladder control, headache, tremors, chronic pain, stroke, minimally conscious state, and spinal cord injury, which are most commonly found in the elderly population. The proven efficacy and improving acceptance of this technology are expected to lead to the surge in the market demand during the forecast period.

Scope of the Report

Neuromodulators are a subset of neurotransmitter. Unlike neurotransmitters, the release of neuromodulators occurs in a diffuse manner. This means that an entire neural tissue may be subject to the neuromodulator's action due to exposure. This, in turn, can tune the neural circuitry of an entire brain region and not just that of an individual neuron.

Key Market Trends

Spinal Cord Stimulation (SCS) Holds the Largest Market Share in the Internal Neuromodulation Type

The process of numbing/reducing chronic pain by passing continuous low voltage electric current to the spinal cord is referred to as spinal cord stimulation (SCS). The SCS devices are FDA approved and are the most widely accepted neurostimulation techniques across the world. These devices are of basic three types namely, rechargeable, conventional, and radiofrequency systems. SCS is used in neurological problems, such as nerve damage, arachnoiditis, failed-back surgery syndrome, neuropathy, complex regional pain syndrome, and neuritis. Along with the associated benefits and effectiveness, SCS also has some pitfalls, such as overstimulation, intermittent stimulation, lead dispositioning, and device malfunctioning. However, the benefits of the SCS outrank the pitfalls, thus boosting the segment's growth over the forecast period.

North America Captured the Largest Market Share and is Expected to Retain its Dominance

North America dominated the overall neuromodulation market with the United States accounting as the major contributor to the market. The presence of major market players and huge pharmaceutical and biopharmaceutical industries, coupled with the rising investments in the country for the adoption of advanced technologies, is expected to boost the regional growth of the market over the forecast period. In addition, the rising concern about the prevalence of neurological disorder and other associated disorders is stimulating the need for the adoption of neuromodulation techniques. Asia-Pacific, on the other hand, is expected to grow with the fastest growth rate over the forecast period.

Competitive Landscape

The major market players in the market include Medtronic PLC, Boston Scientific Corporation, St. Jude Medical Inc., Synapse Biomedical Inc., and Nevro Corporation, among others. The increasing innovation and rise in investment for various public and private organizations are expected to intensify the industry rivalry across the world.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Neurological Disorders
    • 4.2.2 Increase in the Aging Population
    • 4.2.3 Strong Product Pipeline
    • 4.2.4 Expanded Target Applications and New Indications
    • 4.2.5 Growing Investments
  • 4.3 Market Restraints
    • 4.3.1 Inconsistent Reimbursement Policies
    • 4.3.2 Lack of Trained Professionals
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Technology
    • 5.1.1 Internal Neuromodulation
      • 5.1.1.1 Spinal Cord Stimulation (SCS)
      • 5.1.1.2 Deep Brain Stimulation (DBS)
      • 5.1.1.3 Vagus Nerve Stimulation (VNS)
      • 5.1.1.4 Sacral Nerve Stimulation (SNS)
      • 5.1.1.5 Gastric Electrical Stimulation (GES)
    • 5.1.2 External Neuromodulation (Non-Invasive)
      • 5.1.2.1 Transcutaneous Electrical Nerve Stimulation (TENS)
      • 5.1.2.2 Transcranial Magnetic Stimulation (TMS)
      • 5.1.2.3 Respiratory Electrical Stimulation (RES)
  • 5.2 By Application
    • 5.2.1 Parkinson's disease
    • 5.2.2 Epilepsy
    • 5.2.3 Depression
    • 5.2.4 Dystonia
    • 5.2.5 Pain Management
    • 5.2.6 Other Applications
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 US
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 UK
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East & Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East & Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Medtronic PLC
    • 6.1.2 Boston Scientific Corporation
    • 6.1.3 St. Jude Medical Inc.
    • 6.1.4 Synapse Biomedical Inc.
    • 6.1.5 Nevro Corporation
    • 6.1.6 Neurosigma Inc.
    • 6.1.7 Neuropace Inc.
    • 6.1.8 Neuronetics Inc.
    • 6.1.9 Cyberonics Inc.
    • 6.1.10 BioControl Medical

7 MARKET OPPORTUNITIES AND FUTURE TRENDS